Status:
NOT_YET_RECRUITING
Pentoxifylline for Vascular Calcification in Kidney Disease
Lead Sponsor:
Mansoura University
Conditions:
Chronic Kidney Disease
Vascular Calcification
Eligibility:
All Genders
18+ years
Phase:
PHASE1
PHASE2
Brief Summary
This study is research to find out if the drug pentoxifylline can help prevent or lessen the problem of blood vessel hardening (vascular calcification) in people with chronic kidney disease (CKD). Peo...
Eligibility Criteria
Inclusion
- Estimated Glomerular Filtration Rate (eGFR) less than 60 ml/min/1.73 m² and greater than or equal to 15 ml/min/1.73 m².
- Adult patients, age 18 years or older.
- Diagnosis of Chronic Kidney Disease (CKD).
- Willing and able to provide informed consent.
Exclusion
- Patients currently undergoing regular hemodialysis.
- History of kidney transplantation or are kidney transplant recipients.
- Pregnant females.
- Patients with a history of coronary artery bypass grafting (CABG).
- Known allergy or contraindication to pentoxifylline.
- Inability to comply with study procedures or attend follow-up visits.
Key Trial Info
Start Date :
April 15 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 30 2025
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06903689
Start Date
April 15 2025
End Date
October 30 2025
Last Update
April 1 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.